ReviewTherapeutic advances in hematology2014

The potential of panobinostat as a treatment option in patients with relapsed and refractory multiple myeloma.

Claudia V Andreu-Vieyra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.